Ovarian cancer cells (Ovcar3) treated with an activator of the PKC pathway, phorbol-12-myristate 13-acetate (PMA), increased MMP7 and MMP10 mRNA [167,168]. This evidence concerns the gene MMP7 and ovarian carcinoma.